EW
Edwards Lifesciences Corp
NYSE: EW · Irvine, CA
$79.71-1.73 (-2.12%)Closed
Market Cap$46.29B
Cash$2.94Bmost recent
Runwayprofitable
P/E (TTM)43.6EPS $1.83
52-Wk Range$70.46 – $87.18
Avg Volume4.4M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$79.71-8.3%
Pipeline

Drug candidates sponsored by Edwards Lifesciences · ClinicalTrials.gov

99 drugs · 100 trials
PhaseDrug / CandidateIndicationsStatusNext CompletionTrials
Phase 1Unnamed
Mitral Valve Regurgitation
Withdrawn
2019-10past
1
N/AUnnamed
Blood Glucose
Completed
2010-04past
1
N/AUnnamed
Cardiac Output and Preload Assessment+1 more
Completed
2010-12past
1
N/AUnnamed
Aortic Valve Stenosis
Completed
2011-10past
1
N/AUnnamed
Aortic Valve Stenosis
Completed
2013-01past
1
N/AUnnamed
Severe+2 more
Completed
2013-05-01past
1
N/AUnnamed
Pulmonary Regurgitation+2 more
Completed
2013-07past
1
N/AUnnamed
Accurate Blood Glucose Monitoring in Critical Care Setting
Completed
2013-09past
1
N/AUnnamed
Aortic Valve Disease
Completed
2013-09-17past
1
N/AUnnamed
Severe Aortic Stenosis
Completed
2014-08past
1
N/AUnnamed
Aortic Valve Disease+1 more
Completed
2015-03past
1
N/AUnnamed
Mitral Insufficiency+3 more
Terminated
2015-08past
1
N/AUnnamed
Symptomatic Severe Aortic Stenosis
Completed
2015-09past
1
N/AUnnamed
Mitral Valve or Aortic Valve Replacement
Completed
2015-11past
1
N/AUnnamed
Symptomatic Severe Aortic Stenosis
Completed
2015-11-18past
1
N/AUnnamed
Intensive Care Unit Blood Glucose Monitoring
Withdrawn
2015-12past
1
N/AUnnamed
Symptomatic Severe Aortic Stenosis
Completed
2016-01past
1
N/AUnnamed
Severe, Symptomatic Aortic Stenosis
Completed
2016-02past
1
N/AUnnamed
Aortic Stenosis
Completed
2016-02past
1
N/AUnnamed
Aortic Valve Disease+2 more
Completed
2016-04past
1
N/AUnnamed
Aortic Valve Disease+1 more
Completed
2016-04past
1
N/AUnnamed
Mitral Valve or Aortic Valve Replacement
Completed
2016-04-27past
1
N/AUnnamed
Mitral Regurgitation
Completed
2016-06past
1
N/AUnnamed
Mitral Regurgitation
Completed
2016-08past
1
N/AUnnamed
Aortic Valve Disease
Completed
2016-08-22past
1
N/AUnnamed
Aortic Valve Disease+1 more
Completed
2017-04past
1
N/AUnnamed
Mitral Valve or Aortic Valve Replacement
Terminated
2017-04-29past
1
N/AUnnamed
Mitral Valve Regurgitation+2 more
Terminated
2017-06-16past
1
N/AUnnamed
Aortic Stenosis
Completed
2017-10past
1
N/AUnnamed
Mitral Valve Insufficiency+6 more
Terminated
2017-11past
1
N/AUnnamed
Mitral Valve Regurgitation+2 more
Completed
2017-11-06past
1
N/AUnnamed
Aortic Valve Stenosis With Insufficiency+1 more
Completed
2017-12past
1
N/AUnnamed
Tricuspid Valve Insufficiency+6 more
Completed
2018-01-01past
1
N/AUnnamed
Tricuspid Valve Regurgitation
Completed
2018-01-30past
1
N/AUnnamed
Mitral Valve Regurgitation+2 more
Completed
2018-02-08past
1
N/AUnnamed
Aortic Valve Disorder+4 more
Completed
2018-07past
1
N/AUnnamed
Aortic Stenosis+2 more
Completed
2018-07-06past
1
N/AUnnamed
Pulmonary Valve Insufficiency+2 more
Completed
2018-09past
1
N/AUnnamed
Mitral Heart Valve Disease
Completed
2018-11past
1
N/AUnnamed
Non-Cardiac/ Non-Thoracic Surgery+3 more
Completed
2018-12-21past
1
N/AUnnamed
Aortic Stenosis
Active, not recruiting
2019-02-14past
1
N/AUnnamed
Aortic Stenosis+2 more
Completed
2019-07-03past
1
N/AGuideline Directed Medical Therapy
Functional Mitral Regurgitation+2 more
Terminated
2019-07-19past
1
N/AUnnamed
Aortic Valve Stenosis
Completed
2019-08-14past
1
N/AUnnamed
Patient With Clinically Indicated Invasive Monitoring
Completed
2019-10-17past
1
N/AUnnamed
Hypotension
Completed
2020-03-17past
1
N/AUnnamed
Mitral Valve Regurgitation
Completed
2020-07-30past
1
N/AUnnamed
Aortic Valve Stenosis
Active, not recruiting
2020-10-02past
1
N/AUnnamed
Aortic Stenosis
Active, not recruiting
2020-11-16past
1
N/AUnnamed
Mitral Valve Insufficiency
Completed
2021-05-10past
1
N/AUnnamed
Aortic Valve Stenosis+3 more
Completed
2021-05-26past
1
N/AUnnamed
Mitral Regurgitation+1 more
Active, not recruiting
2021-06-16past
1
N/AUnnamed
Pulmonary Valve Insufficiency+5 more
Completed
2021-08-09past
1
N/AUnnamed
Aortic Valve Stenosis
Active, not recruiting
2021-09-24past
1
N/AUnnamed
Sepsis
Unknown
2021-12-31past
1
N/AUnnamed
Pulmonary Disease+4 more
Active, not recruiting
2022-07-14past
1
N/AUnnamed
Mitral Valve Insufficiency+3 more
Active, not recruiting
2022-08-16past
1
N/AUnnamed
Hemodynamic Monitoring
Completed
2022-09-01past
1
N/AUnnamed
Cardiovascular Diseases+1 more
Completed
2022-10-07past
1
N/AUnnamed
Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse
Terminated
2022-11-17past
1
N/AUnnamed
Moderate to High-risk Noncardiac Surgery
Terminated
2022-12-15past
1
N/AUnnamed
Pediatric ALL
Completed
2023-01-05past
1
N/AUnnamed
Tricuspid Valve Insufficiency
Active, not recruiting
2023-04-20past
1
N/AUnnamed
Heart Failure
Withdrawn
2023-12-06past
1
N/AUnnamed
Heart Failure
Active, not recruiting
2023-12-15past
1
N/AUnnamed
Tricuspid Valve Regurgitation+2 more
Active, not recruiting
2024-01-05past
1
N/AUnnamed
Aortic Valve Replacement
Terminated
2024-02-13past
1
N/AUnnamed
Coronary Artery Disease+3 more
Completed
2024-03-06past
1
N/AUnnamed
Blood Pressure
Completed
2024-03-11past
1
N/AUnnamed
Mitral Valve Regurgitation (Degenerative or Functional)
Active, not recruiting
2024-05-04past
1
N/AUnnamed
Aortic Valve Disease+2 more
Active, not recruiting
2024-07-17past
1
N/AUnnamed
Mitral Valve Regurgitation (Degenerative or Functional)
Completed
2025-01-01past
1
N/AUnnamed
Aortic Stenosis, Severe
Active, not recruiting
2025-07-22past
1
N/AUnnamed
Pulmonary Valve Insufficiency+4 more
Active, not recruiting
2025-09-25past
1
N/AUnnamed
Cardiopulmonary Bypass Surgery
Active, not recruiting
2025-10past
1
N/AUnnamed
Moderate to High-risk Noncardiac Surgery
Completed
2025-10-27past
1
N/AUnnamed
Blood Pressure
Recruiting
2025-11past
1
N/AUnnamed
Mitral Regurgitation+1 more
Recruiting
2025-12-31past
1
N/AUnnamed
Hemodynamic Instability
Recruiting
2026-11
1
N/AUnnamed
Blood Pressure
Not yet recruiting
2026-11
1
N/AUnnamed
Heart Failure
Active, not recruiting
2026-11-01
1
N/AUnnamed
Aortic Valve Disease
Recruiting
2026-12
1
N/AUnnamed
Complex Congenital Heart Defect+3 more
Recruiting
2026-12
1
N/AUnnamed
Tricuspid Regurgitation
Active, not recruiting
2026-12-31
1
N/AUnnamed
Mitral Regurgitation+1 more
Recruiting
2027-02-28
1
N/AUnnamed
Aortic Valve Regurgitation+2 more
Not yet recruiting
2027-11
1
N/AUnnamed
Mitral Regurgitation
Active, not recruiting
2027-12-20
1
N/AOptimal Medical Therapy
Tricuspid Valve Regurgitation+6 more
Recruiting
2027-12-31
2
N/AUnnamed
Mitral Stenosis+1 more
Active, not recruiting
2028-01
1
N/AUnnamed
Aortic Valve Regurgitation+1 more
Recruiting
2028-02
1
N/AUnnamed
Mitral Valve Regurgitation (Degenerative or Functional)
Active, not recruiting
2028-04-30
1
N/AUnnamed
Aortic Valve Replacement
Active, not recruiting
2028-12
1
N/AUnnamed
Mitral Valve Replacement
Recruiting
2028-12
1
N/AUnnamed
Mitral Regurgitation+2 more
Not yet recruiting
2029-03
1
N/AUnnamed
Aortic Stenosis, Calcific+1 more
Recruiting
2029-06
1
N/AUnnamed
Tricuspid Valve Regurgitation+2 more
Recruiting
2030-09-30
1
N/AUnnamed
Aortic Valve Replacement
Suspended
2030-12
1
N/AUnnamed
Aortic Stenosis+1 more
Recruiting
2033-01
1
N/AUnnamed
Aortic Stenosis, Severe
Active, not recruiting
2035-12
1
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for EW. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.